Wordt geladen...
Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report
BACKGROUND: Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-ligand 1 agent avelumab, were recently approved for the treatment of advanc...
Bewaard in:
| Gepubliceerd in: | World J Clin Cases |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Inc
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8223835/ https://ncbi.nlm.nih.gov/pubmed/34222455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v9.i18.4829 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|